Skip to main content

Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.

Publication ,  Journal Article
Kuderer, NM; Lyman, GH
Published in: Cancer Invest
November 2009

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Invest

DOI

EISSN

1532-4192

Publication Date

November 2009

Volume

27

Issue

9

Start / End Page

885 / 890

Location

England

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Sensitivity and Specificity
  • Risk Factors
  • Risk Assessment
  • Reproducibility of Results
  • Predictive Value of Tests
  • Oncology & Carcinogenesis
  • Oligonucleotide Array Sequence Analysis
  • Odds Ratio
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kuderer, N. M., & Lyman, G. H. (2009). Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. Cancer Invest, 27(9), 885–890. https://doi.org/10.3109/07357900903275142
Kuderer, Nicole M., and Gary H. Lyman. “Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.Cancer Invest 27, no. 9 (November 2009): 885–90. https://doi.org/10.3109/07357900903275142.
Kuderer, Nicole M., and Gary H. Lyman. “Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.Cancer Invest, vol. 27, no. 9, Nov. 2009, pp. 885–90. Pubmed, doi:10.3109/07357900903275142.

Published In

Cancer Invest

DOI

EISSN

1532-4192

Publication Date

November 2009

Volume

27

Issue

9

Start / End Page

885 / 890

Location

England

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Sensitivity and Specificity
  • Risk Factors
  • Risk Assessment
  • Reproducibility of Results
  • Predictive Value of Tests
  • Oncology & Carcinogenesis
  • Oligonucleotide Array Sequence Analysis
  • Odds Ratio